Cognitive Care, a developer of technologies for screening and monitoring cognitive conditions such as memory loss and Alzheimer's Disease, today announced that it has named Michael Addicott of Addicott Ventures as Managing Director.
Irvine and Menlo Park, CA (PRWEB) February 24, 2004--Cognitive Care, a developer of technologies for screening and monitoring cognitive conditions such as memory loss, today announced that it has named Michael Addicott of Addicott Ventures as Managing Director.
A veteran of several start-ups, Addicott provides hands-on leadership to early stage companies. His background includes experience at UPS where he served as product manager for UPS Online; product strategy at PeopleSoft; supply chain firm Saltare (co-founder and Executive VP) which merged with Vizional Technologies; Portal Wave (founding investor & board member) which merged with Kinzan, Inc., and popular MP3 network DigaCast (President and co-founder).
Addicott will focus on developing and expanding the companys online services and creating subscription-revenue, and he joins present management Josh Reynolds, the companys Founder, and Dr. Robert Heller, Medical Director.
I view the area of memory loss and cognitive impairment as one of the worlds great health challenges, and now with the maturation of the Internet, the time is right for a service that will enable anyone, anywhere, to test and track their memory, based on clinically-approved and patent-protected technology," said Dr. Addicott. Furthermore, with almost 6.5 billion people in the world and over 300 million suffering from some degree of memory loss, coupled with the gradual aging of the population, the opportunity is more important than online package tracking – which became one of the great uses of the Internet."
Dr. Addicott will concentrate on building strategic partnerships and expanding the companys business across sectors, leadership of online efforts and strategic marketing.
About Cognitive Care
Cognitive Care, a privately held company, develops, licenses, and markets software-based services for screening, monitoring, and averting conditions that affect human cognition and motor performance. The company offers subscriptions and software licenses and services for media, government, healthcare, special education, and industrial clients. The company, which has raised almost $7 million for R&D since its inception, has received U.S. patent awards on its technology, administered over half a million tests, and been subject to numerous validity studies on its technology at institutions including Stanford University, University of California, Irvine, Scripps Research Institute, and universities in Canada and Australia.
|
